Biondo Investment Advisors, LLC Illumina, Inc. Transaction History

Biondo Investment Advisors, LLC

$724 Million
Q3 2024

A detailed history of Biondo Investment Advisors, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Biondo Investment Advisors, LLC holds 78,322 shares of ILMN stock, worth $10.6 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares

78,322

Previous 76,113 2.9%

Holding current value

$10.6 Million

Previous $7.94 Million 28.56%

% of portfolio

1.41%

Previous 1.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$105.28 - $135.9 $232,563 - $300,203	2,209 Added 2.9%	78,322 $10.2 Million
Q2 2024 Aug 13, 2024	BUY	$101.05 - $133.57 $329,018 - $434,903	3,256 Added 4.47%	76,113 $7.94 Million
Q1 2024 May 13, 2024	BUY	$127.73 - $147.2 $1.68 Million - $1.94 Million	13,174 Added 22.07%	72,857 $10 Million
Q4 2023 Feb 12, 2024	BUY	$92.79 - $142.53 $963,624 - $1.48 Million	10,385 Added 21.07%	59,683 $8.31 Million
Q3 2023 Nov 09, 2023	SELL	$128.91 - $192.44 $5,285 - $7,890	-41 Reduced 0.08%	49,298 $6.77 Million
Q2 2023 Aug 11, 2023	BUY	$183.43 - $232.67 $47,875 - $60,726	261 Added 0.53%	49,339 $9.25 Million
Q1 2023 May 09, 2023	BUY	$193.75 - $232.55 $323,950 - $388,823	1,672 Added 3.53%	49,078 $11.4 Million
Q4 2022 Feb 09, 2023	SELL	$187.24 - $242.74 $366,428 - $475,042	-1,957 Reduced 3.96%	47,406 $9.59 Million
Q3 2022 Nov 07, 2022	BUY	$177.23 - $227.44 $441,125 - $566,098	2,489 Added 5.31%	49,363 $9.42 Million
Q2 2022 Aug 11, 2022	BUY	$181.58 - $368.0 $1.4 Million - $2.83 Million	7,698 Added 19.65%	46,874 $8.64 Million
Q1 2022 May 12, 2022	BUY	$303.87 - $423.8 $41,022 - $57,213	135 Added 0.35%	39,176 $13.7 Million
Q4 2021 Feb 08, 2022	SELL	$347.28 - $421.83 $632,049 - $767,730	-1,820 Reduced 4.45%	39,041 $14.9 Million
Q3 2021 Nov 09, 2021	BUY	$405.61 - $524.84 $812,436 - $1.05 Million	2,003 Added 5.15%	40,861 $16.6 Million
Q2 2021 Aug 03, 2021	BUY	$372.84 - $481.5 $2.63 Million - $3.4 Million	7,051 Added 22.17%	38,858 $18.4 Million
Q1 2021 May 11, 2021	SELL	$361.28 - $504.76 $99,713 - $139,313	-276 Reduced 0.86%	31,807 $12.2 Million
Q4 2020 Feb 04, 2021	BUY	$292.7 - $370.96 $505,785 - $641,018	1,728 Added 5.69%	32,083 $11.9 Million
Q3 2020 Nov 05, 2020	SELL	$268.51 - $400.74 $73,303 - $109,402	-273 Reduced 0.89%	30,355 $9.38 Million
Q2 2020 Aug 07, 2020	BUY	$256.46 - $373.01 $87,196 - $126,823	340 Added 1.12%	30,628 $11.3 Million
Q1 2020 May 08, 2020	SELL	$209.2 - $335.53 $4.93 Million - $7.91 Million	-23,568 Reduced 43.76%	30,288 $8.27 Million
Q4 2019 Feb 06, 2020	SELL	$288.29 - $335.49 $339,317 - $394,871	-1,177 Reduced 2.14%	53,856 $17.9 Million
Q3 2019 Nov 05, 2019	SELL	$266.84 - $378.23 $749,019 - $1.06 Million	-2,807 Reduced 4.85%	55,033 $16.7 Million
Q2 2019 Aug 06, 2019	BUY	$300.59 - $368.15 $800,170 - $980,015	2,662 Added 4.82%	57,840 $21.3 Million
Q1 2019 May 08, 2019	BUY	$272.57 - $321.18 $963,534 - $1.14 Million	3,535 Added 6.85%	55,178 $17.1 Million
Q4 2018 Feb 08, 2019	SELL	$272.46 - $366.54 $453,645 - $610,289	-1,665 Reduced 3.12%	51,643 $15.5 Million
Q3 2018 Nov 07, 2018	BUY	$279.04 - $367.06 $1 Million - $1.32 Million	3,585 Added 7.21%	53,308 $19.6 Million
Q2 2018 Aug 02, 2018	BUY	$228.17 - $292.07 $549,889 - $703,888	2,410 Added 5.09%	49,723 $13.9 Million
Q1 2018 May 02, 2018	BUY	$209.54 - $253.91 $425,994 - $516,199	2,033 Added 4.49%	47,313 $11.2 Million
Q4 2017 Feb 07, 2018	BUY	$202.23 - $230.03 $337,724 - $384,150	1,670 Added 3.83%	45,280 $9.89 Million
Q3 2017 Nov 08, 2017	BUY	$172.3 - $213.93 $7.51 Million - $9.33 Million	43,610	43,610 $8.69 Million

Others Institutions Holding ILMN

# of Institutions

901

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.2B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biondo Investment Advisors, LLC with notifications on news.

Account

Biondo Investment Advisors, LLC Illumina, Inc. Transaction History